US Stock MarketDetailed Quotes

Entrada Therapeutics (TRDA)

Watchlist
  • 11.710
  • +0.410+3.63%
Close Jan 22 15:59 ET
447.55MMarket Cap-4.56P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entrada Therapeutics (TRDA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-91.75%1.61M
-97.94%1.95M
-65.23%20.56M
63.38%210.78M
-10.63%37.4M
-55.25%19.57M
421.16%94.69M
134.05%59.12M
129.01M
41.85M
Operating revenue
-91.75%1.61M
-97.94%1.95M
-65.23%20.56M
63.38%210.78M
-10.63%37.4M
-55.25%19.57M
421.16%94.69M
134.05%59.12M
--129.01M
--41.85M
Cost of revenue
Gross profit
Operating expense
18.04%48.67M
18.24%48.8M
11.42%42.35M
23.90%163.77M
17.11%43.27M
38.71%41.23M
19.73%41.27M
22.45%38.01M
35.92%132.18M
44.43%36.94M
Selling and administrative expenses
3.34%10.3M
18.25%10.92M
9.31%10.27M
19.12%38.47M
13.95%9.86M
32.38%9.97M
13.06%9.24M
18.41%9.4M
5.39%32.29M
-12.55%8.65M
-General and administrative expense
3.34%10.3M
18.25%10.92M
9.31%10.27M
19.12%38.47M
13.95%9.86M
32.38%9.97M
13.06%9.24M
18.41%9.4M
5.39%32.29M
-12.55%8.65M
Research and development costs
22.73%38.36M
18.24%37.88M
12.12%32.07M
25.45%125.31M
18.08%33.41M
40.85%31.26M
21.81%32.04M
23.83%28.61M
49.96%99.88M
80.37%28.29M
Operating profit
-117.25%-47.05M
-187.69%-46.85M
-203.21%-21.79M
1,586.75%47.01M
-219.61%-5.87M
-254.57%-21.66M
427.77%53.42M
465.28%21.11M
96.75%-3.16M
119.18%4.91M
Net non-operating interest income expense
-38.07%3.57M
-10.12%3.92M
5.39%4.44M
27.97%19.47M
19.48%5.13M
42.34%5.77M
3.51%4.37M
58.60%4.21M
478.19%15.22M
351.79%4.29M
Non-operating interest income
-38.07%3.57M
-10.12%3.92M
5.39%4.44M
27.97%19.47M
19.48%5.13M
42.34%5.77M
3.51%4.37M
58.60%4.21M
478.19%15.22M
351.79%4.29M
Other net income (expense)
Income before tax
-173.60%-43.48M
-174.28%-42.93M
-168.50%-17.35M
451.47%66.49M
-108.04%-739K
-187.98%-15.89M
578.35%57.79M
910.98%25.33M
112.74%12.06M
137.34%9.2M
Income tax
135.16%654K
-93.55%178K
0
-95.42%859K
-109.98%-1.87M
89.31%-1.86M
-80.08%2.76M
-48.44%1.83M
18.74M
18.74M
Net income
-214.52%-44.13M
-178.32%-43.1M
-173.84%-17.35M
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
Net income continuous Operations
-214.52%-44.13M
-178.32%-43.1M
-173.84%-17.35M
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
Minority interest income
Net income attributable to the parent company
-214.52%-44.13M
-178.32%-43.1M
-173.84%-17.35M
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-214.52%-44.13M
-178.32%-43.1M
-173.84%-17.35M
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
Basic earnings per share
-202.86%-1.06
-164.60%-1.04
-160.00%-0.42
980.00%1.76
110.34%0.03
-132.71%-0.35
306.41%1.61
433.33%0.7
93.38%-0.2
63.29%-0.29
Diluted earnings per share
-202.86%-1.06
-167.10%-1.04
-161.76%-0.42
940.00%1.68
110.34%0.03
-134.31%-0.35
298.72%1.55
423.81%0.68
93.38%-0.2
63.29%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -91.75%1.61M-97.94%1.95M-65.23%20.56M63.38%210.78M-10.63%37.4M-55.25%19.57M421.16%94.69M134.05%59.12M129.01M41.85M
Operating revenue -91.75%1.61M-97.94%1.95M-65.23%20.56M63.38%210.78M-10.63%37.4M-55.25%19.57M421.16%94.69M134.05%59.12M--129.01M--41.85M
Cost of revenue
Gross profit
Operating expense 18.04%48.67M18.24%48.8M11.42%42.35M23.90%163.77M17.11%43.27M38.71%41.23M19.73%41.27M22.45%38.01M35.92%132.18M44.43%36.94M
Selling and administrative expenses 3.34%10.3M18.25%10.92M9.31%10.27M19.12%38.47M13.95%9.86M32.38%9.97M13.06%9.24M18.41%9.4M5.39%32.29M-12.55%8.65M
-General and administrative expense 3.34%10.3M18.25%10.92M9.31%10.27M19.12%38.47M13.95%9.86M32.38%9.97M13.06%9.24M18.41%9.4M5.39%32.29M-12.55%8.65M
Research and development costs 22.73%38.36M18.24%37.88M12.12%32.07M25.45%125.31M18.08%33.41M40.85%31.26M21.81%32.04M23.83%28.61M49.96%99.88M80.37%28.29M
Operating profit -117.25%-47.05M-187.69%-46.85M-203.21%-21.79M1,586.75%47.01M-219.61%-5.87M-254.57%-21.66M427.77%53.42M465.28%21.11M96.75%-3.16M119.18%4.91M
Net non-operating interest income expense -38.07%3.57M-10.12%3.92M5.39%4.44M27.97%19.47M19.48%5.13M42.34%5.77M3.51%4.37M58.60%4.21M478.19%15.22M351.79%4.29M
Non-operating interest income -38.07%3.57M-10.12%3.92M5.39%4.44M27.97%19.47M19.48%5.13M42.34%5.77M3.51%4.37M58.60%4.21M478.19%15.22M351.79%4.29M
Other net income (expense)
Income before tax -173.60%-43.48M-174.28%-42.93M-168.50%-17.35M451.47%66.49M-108.04%-739K-187.98%-15.89M578.35%57.79M910.98%25.33M112.74%12.06M137.34%9.2M
Income tax 135.16%654K-93.55%178K0-95.42%859K-109.98%-1.87M89.31%-1.86M-80.08%2.76M-48.44%1.83M18.74M18.74M
Net income -214.52%-44.13M-178.32%-43.1M-173.84%-17.35M1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M
Net income continuous Operations -214.52%-44.13M-178.32%-43.1M-173.84%-17.35M1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M
Minority interest income
Net income attributable to the parent company -214.52%-44.13M-178.32%-43.1M-173.84%-17.35M1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -214.52%-44.13M-178.32%-43.1M-173.84%-17.35M1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M
Basic earnings per share -202.86%-1.06-164.60%-1.04-160.00%-0.42980.00%1.76110.34%0.03-132.71%-0.35306.41%1.61433.33%0.793.38%-0.263.29%-0.29
Diluted earnings per share -202.86%-1.06-167.10%-1.04-161.76%-0.42940.00%1.68110.34%0.03-134.31%-0.35298.72%1.55423.81%0.6893.38%-0.263.29%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -